Hong Kong Stock Exchange motion | Goli Pharmaceutical-B (01672.HK) surged more than 6% in the afternoon, ASC50 treatment for psoriasis completes the first batch of dosing in the United States Phase I clinical trial.

According to the Securities Times app, Geely Pharmaceutical-B (01672.HK) surged more than 6% in the afternoon, as of the time of writing, it rose by 4.82% to 9.35 Hong Kong dollars, with a turnover of 32.9579 million Hong Kong dollars.